HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kinetics of arylamine N-acetyltransferase in tissues from human breast cancer.

Abstract
N-Acetyltransferase activity and Michaelis-Menten kinetic constants were determined in cancerous and non-cancerous breast tissues from 30 female patients with breast cancer. The results derived from tissue cytosol showed that 12 rapid, ten intermediate and eight slow acetylators based on p-aminobenzoic acid and 2-aminofluorene for substrates. The mean apparent Km values for the monomorphic substrate p-aminobenzoic acid and polymorphic substrate 2-aminofluorene were: 55.0 +/- 18.7, 114.0 +/- 30.0, and 137.0 +/- 37.2 microM; and 62.5 +/- 23.7, 166.0 +/- 67.0, and 239.0 +/- 76.6 microM for the slow, intermediate, and rapid enzymes, respectively. Compared to the enzymes from slow acetylators, the rapid acetylators exhibited mean apparent Vmax values eight- and ten-fold greater for p-aminobenzoic acid and 2-aminofluorene, respectively. A similar trend was obtained from the blood cytosols of cancerous patients and healthy volunteers. N-Acetyltransferase activity of breast cancerous and non-cancerous tissues were 1.5- and 2.2-fold different between rapid and slow acetylator with p-aminobenzoic acid and 2-aminofluorene as substrates, respectively. In breast cancerous tissues, 75% and 70% of the cytosolic N-acetyltransferase activity were inhibited under 2 mM of tamoxifen as substrates of 2-aminofluorene and p-aminobenzoic acid, respectively. Similar results were also found in non-cancerous tissues and blood samples from breast cancer patients and healthy volunteers. The effect of 1 mM tamoxifen on the N-acetyltransferase activity from breast cancerous tissues with positive estrogen receptor was 1.6-fold higher than that of negative estrogen receptor. This is the first demonstration to show that anti-estrogen drug can affect N-acetyltransferase activity in breast cancerous tissues. Therefore, this finding may provide a clue to the use of tamoxifen in prevention of human breast cancer.
AuthorsJ H Lee, J G Chung, J M Lai, G N Levy, W W Weber
JournalCancer letters (Cancer Lett) Vol. 111 Issue 1-2 Pg. 39-50 (Jan 01 1997) ISSN: 0304-3835 [Print] Ireland
PMID9022126 (Publication Type: Journal Article)
Chemical References
  • Anticarcinogenic Agents
  • Carcinogens
  • Fluorenes
  • Neoplasm Proteins
  • Tamoxifen
  • 2-aminofluorene
  • Arylamine N-Acetyltransferase
  • 4-Aminobenzoic Acid
Topics
  • 4-Aminobenzoic Acid (metabolism)
  • Acetylation
  • Anticarcinogenic Agents (pharmacology)
  • Arylamine N-Acetyltransferase (metabolism)
  • Breast (enzymology)
  • Breast Neoplasms (enzymology)
  • Carcinogens (metabolism)
  • Female
  • Fluorenes (metabolism)
  • Humans
  • Neoplasm Proteins (metabolism)
  • Phenotype
  • Tamoxifen (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: